Literature DB >> 11794176

Hemodynamic and metabolic therapy in critically ill patients.

T W Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11794176     DOI： 10.1056/NEJM200111083451910

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  [Progress in therapy of infection].

Authors:  U Müller-Werdan; M Buerke; K Werdan
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 2.  General medical care on the neuromedical intensive care unit.

Authors:  Robin S Howard; Jeremy Radcliffe; Nicholas P Hirsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

3.  Improving outcomes in patients with acute coronary syndromes.

Authors:  Mustafa Tiewala; Alexander Perkevald; Cristina Ogrin; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

4.  Analyses of longitudinal, hospital clinical laboratory data with application to blood glucose concentrations.

Authors:  Jonathan S Schildcrout; Sebastien Haneuse; Josh F Peterson; Joshua C Denny; Michael E Matheny; Lemuel R Waitman; Randolph A Miller
Journal:  Stat Med       Date:  2011-09-21       Impact factor: 2.373

5.  Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients.

Authors:  Atul Kulkarni; Manoj Saxena; Grant Price; Michael J O'Leary; Theresa Jacques; John A Myburgh
Journal:  Intensive Care Med       Date:  2004-11-23       Impact factor: 17.440

Review 6.  Stress-hyperglycemia, insulin and immunomodulation in sepsis.

Authors:  Paul E Marik; Murugan Raghavan
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

Review 7.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

8.  Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: A two-center cohort study.

Authors:  Fen Xiao; Ying-Chu Zhou; Mei-Biao Zhang; Dong Chen; Shao-Lin Peng; Hao-Neng Tang; Long Li; Chen-Yi Tang; Ji-Yang Liu; Bo Li; Hou-De Zhou
Journal:  J Med Virol       Date:  2022-01-08       Impact factor: 20.693

9.  Hyperglycemia increases the complicated infection and mortality rates during induction therapy in adult acute leukemia patients.

Authors:  Carolina do Nascimento Matias; Vladmir Lima; Heberton Medeiros Teixeira; Fernanda Ribeiro Souto; Vera Magalhães
Journal:  Rev Bras Hematol Hemoter       Date:  2013

10.  Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study.

Authors:  Kirsi-Maija Kaukonen; Michael Bailey; David Pilcher; Neil Orford; Simon Finfer; Rinaldo Bellomo
Journal:  Crit Care       Date:  2013-10-02       Impact factor: 9.097
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.